This report describes a preterm infant hospitalized in a neonatal intensive care unit who developed Pseudomonas aeruginosa conjunctivitis associated with bacteremia, meningitis, and multiple brain abscesses. P. aeruginosa conjunctivitis can rapidly progress to an invasive eye infection, such as corneal ulceration or endophthalmitis, leading to poor vision or blindness. Progression of this infection may lead to systemic disease. However, as illustrated in this report, P. aeruginosa conjunctivitis may be associated with the development of systemic complications such as bacteremia and meningitis in the absence of invasive eye disease. P. aeruginosa is a relatively common cause of conjunctivitis in hospitalized preterm and low birth weight infants. Given the severity of the ocular and systemic complications of Pseudomonas conjunctivitis, clinicians are reminded that prompt detection and treatment of neonatal conjunctivitis is critical.
CASE REPORT
An infant boy was born by cesarean section at 27 weeks' gestation due to a prolapsed umbilical cord. The infant's birth weight was 910 gm, and Apgar scores were 5 and 6 at 1 and 5 minutes, respectively. The infant required mechanical ventilation for treatment of respiratory distress syndrome for the first 11 days of life. On day 12 of life, a purulent conjunctivitis of the right eye was noted and a conjunctival bacterial culture was obtained.
On day 13 of life, the infant developed signs and symptoms of septic shock. Physical exam was remarkable for a heart rate of 220 beats per minute, respirations at 40 to 50/min, and blood pressure at 30/20 mm Hg. The infant was lethargic but had normal upper and lower extremity tone. The anterior fontanelle was flat. There was decreased perfusion with cold extremities and delayed capillary refill. This deterioration was accompanied by metabolic acidosis. The white blood cell count was 50,900/mm 3 with 59% segmented neutrophils and 17% band forms. The platelet count was 20,000/mm 3 , and prothrombin and partial thromboplastin times were prolonged at 26.5 seconds and Ͼ2 minutes, respectively. Cerebrospinal fluid examination revealed a glucose of 22 mg/dl, a protein of 164 mg/dl, 5/mm 3 erythrocytes, and 387/mm 3 leukocytes. Blood, urine, endotracheal secretion, and cerebrospinal fluid cultures were obtained. Cranial ultrasonography was normal. Treatment included intravenous fluid boluses, dopamine infusion, mechanical ventilation, and transfusion with packed red blood cells, fresh frozen plasma, and platelets. Intravenous ampicillin and ceftriaxone were prescribed. These were subsequently changed to intravenous gentamicin and ceftazidime when Pseudomonas aeruginosa was isolated from blood, endotracheal, and conjunctival cultures. Both eyes were treated with ophthalmic gentamicin ointment.
The infant's condition remained poor over the next week. Although his conjunctivitis had resolved, he was still lethargic with poor perfusion. He continued to require mechanical ventilation and pressor support as well as multiple packed red blood cell, platelet, and fresh frozen plasma transfusions for treatment of ongoing disseminated intravascular coagulation. On day 20 of life, he was noted to be irritable with increased lower extremity extensor tone, a depressed anterior fontanelle, and an absent right plantar grasp. Repeat cranial ultrasonography revealed a new left-sided grade I germinal matrix hemorrhage and two 3-to 5-mm spherical, cystic lesions in the left cerebral hemisphere consistent with brain abscesses (Figure 1, left) . Electroencephalogram was abnormal, with excessive asynchrony and diffuse slowing without evidence of focal or epileptiform abnormalities. Abdominal ultrasonography, echocardiography, and fundoscopic examination did not reveal any other sites of infection. A new 2-mm cavitary lesion was noted in the right frontoparietal region on day 26 of life ( Figure 1, right) , but repeat blood, endotracheal secretion, and cerebrospinal fluid cultures were sterile. The brain abscesses were not considered to be large enough for surgical aspiration.
The infant had a gradual improvement in his clinical status with resolution of his cerebrospinal fluid pleocytosis by day 28 of life. The infant received a 6-week course of intravenous gentamicin and ceftazidime. Magnetic resonance imaging performed on day 58 of life showed brain abscesses without evidence of active inflammation (Figure 2) . At discharge on day 65 of life, the infant had increased extensor tone of both lower extremities but no focal neurological deficits.
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On follow-up examination at 3 years of age, the child was found to have severely delayed receptive and expressive language skills. He suffered no long-term ophthalmologic complications.
DISCUSSION
Pseudomonas aeruginosa, an aerobic Gram-negative bacillus, is a readily recognizable nosocomial pathogen capable of causing infection among susceptible hospital patients. Preterm infants are at risk for infection with this organism because they are immunoincompetent and are more likely to require invasive procedures and prolonged hospitalization. In this population, P. aeruginosa may be a virulent pathogen. A 50% fatality rate in very low birth weight infants with systemic P. aeruginosa infection has been reported. 1 Pseudomonas species account for ϳ9.1% of all neonatal nosocomial infections, 2 including malignant external otitis, endocarditis, meningitis, pneumonia, bacteremia, urinary tract infections, dermatitis, and conjunctivitis.
3 P. aeruginosa comprises 1.2% to 5.9% of all cases of neonatal conjunctivitis, 4 -6 and extraocular colonization with P. aeruginosa, particularly in the respiratory tract, may be a predisposing factor. 7 P. aeruginosa conjunctivitis in infancy may be associated with significant morbidity and mortality due to the development of both ophthalmic and systemic complications ( Table 1 ). The infection begins as a purulent conjunctivitis and may progress to infiltration of the corneal stroma. Infiltrating polymorphonuclear leukocytes and the cornea itself may also produce collagenases that contribute to corneal ulceration. 17, 18 Continued spread of the infection may lead to corneal perforation, endophthalmitis, panophthalmitis, and orbital cellulitis. Poor vision or blindness may result. 3, 9, 19 In some cases, subsequent systemic complications such as bacteremia and death occur. 19 -21 P. aeruginosa conjunctivitis has also been associated with systemic complications in the absence of invasive eye infection. 6, 8 In one study, 7 of 18 hospitalized infants with P. aeruginosa conjunctivitis, one of whom is the subject of this detailed report, developed systemic P. aeruginosa infection without evidence of invasive eye disease. 6 Of these 18 infants, 5 were bacteremic and 3 also had meningitis. The reason for the association between P. aeruginosa conjunctivitis and systemic infection is not known. The conjunctivae may serve as the portal of entry for systemic infection. Alternatively, the presence of P. aeruginosa conjunctivitis in infants who later develop systemic P. aeruginosa infection may indicate that the infant was colonized at many sites, one of which served as the source of infection.
Meningitis as a complication of neonatal bacterial conjunctivitis has been reported for other organisms, including group B streptococci, 22 Streptococcus pneumoniae, 23 and Neisseria meningitidis. 24, 25 Meningitis may develop following intracranial invasion of organisms from a contiguous extracranial source or, more commonly, as a result of hematogenous spread from a distant focus of infection. 26, 27 Typically, brain abscesses arising from parameningeal foci are single and are located in the temporal or frontal lobes, whereas those arising from distant foci are multiple and occur widely throughout the brain. 26 In our patient, there was no evidence of Pseudomonas invasion into the globe or orbit; thus both the meningitis and brain abscesses were most likely secondary to bacteremia associated with P. aeruginosa conjunctivitis rather than a direct extension of the infection.
It is impossible to make the diagnosis of neonatal P. aeruginosa conjunctivitis on clinical grounds alone. The clinical manifestations of conjunctivitis due to P. aeruginosa are similar to the clinical manifestations of other bacterial causes of conjunctivitis and include fibrinopurulent exudate, edema, and reactive hyperemia. 28 In addition, there can be significant overlap in both incubation period and clinical findings with conjunctivitis due to other causes such as chemically induced, gonococcal, and chlamydial conjunctivitis. However, unlike other causes of neonatal conjunctivitis, P. aeruginosa appears to have a predilection for preterm infants (Table 2) .
Because neonatal conjunctivitis can lead to permanent visual loss and significant systemic infection even in full-term infants, prompt, careful evaluation and aggressive treatment are needed for all cases of neonatal conjunctivitis. Ophthalmic consultation should be considered an important part of this evaluation, as it improves the chances that adequate conjunctival scrapings are obtained for Gram stain, bacterial cultures, chlamydial studies, and herpes simplex studies. 34 An ophthalmologist using a portable slit lamp can determine if the conjunctivitis is progressing to corneal ulceration and can usually diagnose herpes simplex infection on examination alone.
Although various factors in the neonatal intensive care unit may influence conjunctival flora, 35, 36 P. aeruginosa does not constitute the normal bacteria flora of the healthy eye, even in hospitalized infants. 35 Therefore, the presence of Gram-negative rods on a Gramstained conjunctival specimen from a hospitalized infant with purulent conjunctivitis, particularly a preterm, extremely low birth weight infant, should raise the suspicion for P. aeruginosa infection. In such cases, a complete sepsis evaluation, including blood cultures, should be performed. Furthermore, since P. aeruginosa conjunctivitis has been associated with the rapid development of both ocular and systemic complications, 6,8 -16 treatment with topical and parenteral antipseudomonal therapy (usually an aminoglycoside or a thirdgeneration cephalosporin) should be considered until conjunctival and blood culture results and susceptibility patterns are known.
The prognosis of P. aeruginosa conjunctivitis is variable. Rapid progression to endophthalmitis or bacteremia leading to loss of vision or death may still occur despite early detection and treatment. 8, 9 In summary, P. aeruginosa is a relatively common but potentially serious cause of conjunctivitis in hospitalized preterm and low birth weight infants. P. aeruginosa conjunctivitis may be associated with significant morbidity due to ocular or systemic complications, and, in some cases, death. These observations emphasize the need for early detection and treatment of this infection in the neonatal population.
